Peter C. Adamson, MD

Peter C. Adamson, MD
Chair, Children’s Oncology Group
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania

Peter C. Adamson, M.D. is chair of the Children’s Oncology Group (COG), a National Cancer Institute (NCI) supported international consortium of more than 220 childhood centers that conducts clinical-translational research, including large-scale clinical trials, in children with cancer. He is professor of pediatrics and pharmacology at the University of Pennsylvania School of Medicine and chief of the division of clinical pharmacology and therapeutics at The Children’s Hospital of Philadelphia. Dr. Adamson is board certified in pediatric hematology/oncology and in clinical pharmacology. He is an internationally recognized leader in pediatric cancer drug development, having served until 2008 as chair of the COG’s Developmental Therapeutics Program. Prior to becoming chair of the COG, Dr. Adamson served as director for clinical and translational research at The Children’s Hospital of Philadelphia. His laboratory focuses on the clinical pharmacology of new drugs for childhood cancer.


* Dr. Adamson participated in the review of the Letters of Intent, but not the Full Proposals.